Browse by Medical Category
Research at Mass General
Our research program focuses on the connections between mental health, behavior, and medical health in patients with heart disease and other chronic conditions.
We are interested in the impact of mood and anxiety disorders on cardiac health, and how different treatments for these disorders may impact quality of life and function. Depression and anxiety have been identified as risk factors for poor cardiac outcomes and death, independent of traditional cardiac risk factors such as high blood pressure, smoking or diabetes.
Unfortunately, depression and anxiety go unrecognized and untreated in the vast majority of patients with heart disease, despite the existence of safe and effective treatment. We have performed two randomized trials of care management for cardiac patients who have depression or anxiety disorders to determine whether having a care manager helps these patients to have better outcomes and better quality of life, and have examined the impact of psychiatric medications on cardiac health.
Also, we are increasingly interested in the role of positive thoughts and emotions in health. There is some suggestion that positive psychological states, like optimism, positive affect and self-efficacy in persons may independently predict superior health, yet these connections have not been closely studied in patients who have chronic or acute illnesses, like an acute coronary syndrome or type 2 diabetes.
We have adapted positive psychological exercises to this population to determine if such exercises can boost optimism, positive affect, and self-efficacy in persons with heart disease or type 2 diabetes. We are performing ongoing studies to better develop these exercises and to determine whether they may affect biology, health behaviors, and key cardiac outcomes. We are also working to adapt these positive psychological interventions to patients with diabetes and other medical illnesses.
Finally, we are exploring the use of positive psychological interventions for patients with serious mood disorders or recent suicide attempts, to determine whether cultivating positive states provides benefit in these populations as well. Optimism and other positive states have been linked to lower rates of suicidal thoughts and suicide attempts, and an approach that focuses on this aspect of mental health may be a novel and powerful approach.
Click on the tabs to learn more about our team, our projects, and our publications.
To find out more about our projects and team, contact us at (617) 724-9141 or at firstname.lastname@example.org
Jeff Huffman, MD, is the Director of the Cardiac Psychiatry Research Program (CPRP), Director of Inpatient Psychiatry Research, and an Associate Professor of Psychiatry at Harvard Medical School. He currently serves as principal investigator for over ten projects, and has been awarded grants from the American Heart Association, American Diabetes Association, the Templeton Foundation, American Foundation for Suicide Prevention, and the National Institutes of Health (NHLBI and NIDDK). He has numerous peer-reviewed publications, including 100 first or senior author publications. He has mentored post doctoral psychology fellows, junior psychiatrist and psychologist faculty, medical students, psychiatry residents, research fellows, psychologists, social workers, and he received the 2015 MGH Psychiatry Outstanding Research Mentor Award. His areas of interest include the impact of psychiatric illness on patients with cardiac disease, and the development and use of positive psychological interventions in a wide range of populations.
Christopher Celano, MD, is an attending psychiatrist at Massachusetts General Hospital, an Assistant Professor in Psychiatry at Harvard Medical School, and the Associate Director of the CPRP. He is the recipient of a K23 career development award sponsored by the National Heart, Lung, and Blood Institute to develop a psychological intervention to improve health behaviors in patients with heart failure. He has published over 35 articles with the team, is an active co-investigator on several projects, and serves as the project director of health behavior trials in patients with coronary artery disease and diabetes. His areas of interest include the impact of depression and anxiety on cardiac health as well as the promotion of positive psychological states and health behaviors in patients with mental illness and cardiovascular disease.
Scott Beach, MD, is an Assistant Professor in Psychiatry at Harvard Medical School. He is Program Director for the MGH/McLean Adult Psychiatry Residency and an attending psychiatrist on the consultation service at MGH. He is currently PI of a study investigating neuroimaging and gene expression in patients with catatonia prior to and following lysis with lorazepam, and an active co-investigator on multiple projects. He has published over 50 book chapters and peer-reviewed articles on topics including QTc prolongation with psychotropic medications, catatonia, and deception syndromes.
James Januzzi, MD, is an Associate Professor of Medicine in the Division of Cardiology at Harvard Medical School, and the Director of the Cardiac Intensive Care Unit at Massachusetts General Hospital. He is a well-established researcher at Mass General with over 300 peer-reviewed research publications, over 100 review articles and chapters, and has edited three text books. He is internationally known as an expert in the study of biomarkers in patients with heart failure and other cardiac illnesses, and has served as a section editor on the recent American College of Cardiology/American Heart Association clinical practice guidelines for heart failure, and was the lead for the heart failure section for the Universal Definition of Myocardial Infarction Global Task Force. He has served as the primary cardiologist on projects for the CPRP for the past nine years, including collaborative care depression and anxiety management trials in hospitalized cardiac patients, and studies of positive psychological states in persons with heart disease.
Laura Duque, MD, is a research fellow at the CPRP. Her areas of interest include Consultation Liaison Psychiatry, catatonia, and mood disorders. She is primarily interested in studying the relationship between mental health and chronic diseases. Currently, she is in charge of medical data collection and participant screening for a study on a collaborative care intervention for cardiac inpatients with psychiatric comorbidities, as well as for four positive psychology interventions for individuals with acute coronary syndrome, diabetes, heart failure, and metabolic syndrome. She graduated from Universidad de los Andes School of Medicine in Bogotá, Colombia and intends to apply for residency training in psychiatry this upcoming year.
Perla M. Romero, MD is a research fellow at the CPRP. She was born and raised in Bogotá, Colombia, where she also attended Universidad de los Andes School of Medicine. During her studies, she was involved in several research projects, including an original investigation analyzing the association between armed conflict, violence and mental health. Her main interests include human behavior, neuroscience and mental health. Perla's main goal is to pursue a psychiatry training in the US, and intends to pursue an academic career dedicated to this specialty.
Juan Pablo Ospina, MD, is a research fellow at the CPRP. He graduated from Universidad de los Andes school of Medicine in Bogotá, Colombia. He is interested in the intersection of Neurology and Psychiatry and in studying mind-brain-body interactions. At the CPRP, he oversees subject screening and medical data collection for several randomized clinical trials studying the impact of positive psychology and blended care interventions in patients with medical conditions including acute coronary syndrome, heart failure, diabetes and multiple sclerosis. Likewise, he contributes to the presentation of study findings in publications and poster sessions. In the future, he intends to apply to Neurology residency training.
Franklin King, MD, is an attending psychiatrist at MGH and an Instructor in Psychiatry at Harvard Medical School. He joined the CPRP in 2018, after completing a fellowship in consult-liaison psychiatry at MGH in 2018 and residency at MGH/McLean in 2017, where he also served as consult-liaison chief resident during his fourth year. He graduated from UMass Medical School in 2013. His clinical interests include disorders at the intersection of medicine and psychiatry, the mind-body interface, and neuropsychiatry.
Carol Mastromauro, MSW, LICSW, is one of the interventionists for the CPRP. She is a clinical research social worker who has been with the team for seven years. Carol specializes in anxiety and depression treatment and positive psychology interventions for cardiac populations. She has administered interventions to more than 200 subjects during her time at the CPRP, and recruited and evaluated over 350 cardiac inpatients for the SUCCEED and MOSAIC studies. Prior to joining the CPRP, Carol worked in geriatric research on memory disorders as well as working with Huntington’s disease patients and their families.
Rachel Millstein, PhD, MHS, is a clinical psychologist at MGH and Assistant in Psychiatry at Harvard Medical School. She is the recipient of a National Institutes of Health K23 award to develop a multilevel intervention to promote health behaviors among patients with metabolic syndrome. Her research focuses on chronic disease prevention and the intersection of emotions and health. Rachel has authored many peer-reviewed articles and book chapters in these fields. Her clinical interests include evidence-based therapies, positive psychology, and mindfulness techniques for improving mood, anxiety, and well-being.
Emily Feig, PhD, is a research and clinical post-doctoral psychology fellow in her second year with the CPRP. She completed her doctoral training in clinical psychology at Drexel University and her doctoral internship in Health Psychology at Rush University Medical Center. Emily is an interventionist on the BEHOLD study. Her research interests focus on understanding risk factors for obesity and eating disorders, as well as improving adherence to health behaviors in individuals with obesity-related chronic disease. Clinically, Emily specializes in cognitive behavioral and acceptance-based therapies targeting anxiety, depression, and disordered eating.
Christina Massey, PhD, is a clinical psychologist at MGH and Instructor at Harvard Medical School in her first year with the CPRP. She completed her doctoral training in clinical psychology with a specialization in forensic psychology at The Graduate Center, CUNY at John Jay College of Criminal Justice and her doctoral internship at MGH. Christina is currently an interventionist on the BEHOLD study. Her clinical and research interests include evidence-based treatments, diagnostic and forensic assessment and evaluation, and investigating the long-term consequences (including resilience) of childhood adversity.
Wei-Jean Chung, PhD, is a clinical psychologist at MGH and Instructor at Harvard Medical School. She received her doctoral training in clinical psychology at Adelphi University prior to completing her doctoral internship and postdoctoral fellowship at MGH. She is currently an interventionist for the PEACE and BEHOLD Studies at the CPRP. In addition to her involvement with the CPRP, her clinical practice involves caring for people with serious mental illness and complex personality organization across multiple clinical services within MGH Psychiatry, including Primary Care Psychiatry, the Dialectical Behavioral Therapy Team, the Psychological Evaluation and Research Laboratory, and the MGH inpatient psychiatry service.
Lydia Brown, PhD, is a psychologist and postdoctoral researcher with an interest in links between positive emotional/cognitive qualities and health. She completed her PhD and clinical training at The University of Melbourne, Australia, where she continues to hold a joint academic position. She has a particular interest in self-compassion, as well as novel interventions that might simultaneously boost both mental and physical health in the second half of life.
Margaret C. Bell, RN, MPH, MS, works as a nurse care manager in the CPRP’s Total Health Study, a blended care intervention trial for patients with comorbid heart disease and mood or anxiety disorders. She is a registered nurse with a master’s degree in psychiatric nursing from Boston College in 1994. Her work at Boston College included publications on Russian immigrant adjustment, effect of post-partum depression on mother-child interaction and domestic violence in pregnant women. She has worked in health care in Jerusalem, Amsterdam, New York, New Hampshire and Boston as a public health nurse, student health nurse, and psychiatric nurse. For the last 20 years she has monitored and managed NIH multi-site research trials in hepatology and cardiac research.
Beth Pino-Mauch, RN, BSN, works as a nurse care manager in the CPRP’s Total Health Study, a blended care intervention trial for patients with comorbid heart disease and mood or anxiety disorders. Beth graduated from Boston College in 1983. She has worked as a cardiac and critical care nurse for over 15 years. Beth has also worked for a Boston-based Academic Research Organization as both a Project Manager, and subsequently, a Clinical Nurse Reviewer of reported Serious Adverse Events in several FDA-monitored medical device trials for coronary intervention.
Melanie Freedman, BS, graduated cum laude from Northeastern University in 2015 with a degree in psychology. She is a senior member of the CPRP, serving as the primary research coordinator for the REACH for Health Study. In this role, she is responsible for recruitment, enrollment, and managing study materials. She is also serving as the sole interventionist for a pilot trial of a positive psychology intervention in patients with Multiple Sclerosis through the Partners MS Center (PI: Glanz). Previously, Melanie worked as a research assistant at the Lifespan Emotional Development Lab at Northeastern University, which investigated emotion regulation and attention throughout the lifespan. She then worked as a Resource Specialist on the inpatient psychiatric unit at MGH before joining the CPRP.
Diana Smith, BA, graduated magna cum laude from Harvard University in 2017, with a degree in cognitive neuroscience and evolutionary psychology. She is in her second year with the CPRP and primarily manages the Total Health study, a blended care intervention trial for patients with comorbid heart disease and mood or anxiety disorders. She is also the primary coordinator for an ongoing project (PI: Nock), which is a real-time assessment of suicidal thoughts among psychiatric inpatients. In addition to her role at the CPRP, she volunteers for Samaritans, a suicide prevention and crisis line in Boston. Diana is currently applying to MD/PhD programs to begin in Fall 2019.
Sonia Kim, BA, graduated from UCLA in 2015 summa cum laude with a degree in psychology. She is in her first year with the program and is serving as the primary research coordinator for the MAPP (a PP-MI behavioral intervention study for patients with metabolic syndrome) and NCCP (a pilot care management intervention project for patients with non-cardiac chest pain). Before joining the CPRP, she worked as a rehabilitation specialist at the Sound End Community Health Center, working with underserved population that suffers from severe psychiatric illnesses. Previously in college, she was involved in an fMRI research in Dr. Matthew Lieberman’s lab, investigating the neural and behavioral effects of neuropeptides on human social cognition.
Julia Golden, BA, graduated from Mount Holyoke College in 2015 summa cum laude with a degree in psychology. Currently in her first year with the program, she is serving as the primary research coordinator for the BEHOLD studies. In this role, she is responsible for recruiting and enrolling diabetes patients as well as for organizing and managing study-related data. Previously, Julia worked as a research assistant at the Institute of Living, Hartford Hospital’s psychiatric division, and was involved in studies related to mood disorders and metabolic syndrome in young adult patients. This past year she completed a post-baccalaureate pre-medical program at the University of Virginia.
Carlyn Scheu, BS, graduated cum laude from the University of Denver in 2018 with a degree in biology and psychology. In her first year with the program, Carlyn works primarily on the Dexmedetomidine study, a trial for the use of a sedative drug in patients with probable Alzheimer’s disease. She is also the primary coordinator for the PATH study, which focuses on a positive psychology intervention for cancer patients who have had a hematopoietic stem cell transplant. Prior to her involvement with the CPRP, Carlyn worked as a research assistant for the Traumatic Stress Studies Group at the University of Denver, which seeks to understand complex consequences of trauma and how to improve outcomes for trauma survivors.
Brian Healy, PhD, is an Assistant Professor in the Department of Neurology at Harvard Medical School, a member of the Biostatistics Center at Massachusetts General Hospital, and an Instructor in Biostatistics at the Harvard School of Public Health. Dr. Healy is also the lead biostatistician for the Partners Multiple Sclerosis Center, which is affiliated with Brigham and Women's Hospital. His primary research interest is statistical methods development and application for modeling of multiple sclerosis. He has been working with the CPRP for the past 5 years, and he has participated in the design and analysis of several studies.
Elizabeth Madva, MD, is a fourth year resident in the MGH/McLean psychiatry residency program and a member of the residency's Research Concentration Program and Clinician Educator Program. She is currently serving as the MGH administrative chief resident and the MGH Consultation-Liaison Psychiatry chief resident. She graduated from Weill Cornell Medical College in 2015 and from Yale University in 2008, magna cum laude, with a BA in Cognitive Science. She is a member of the Alpha Omega Alpha and Phi Beta Kappa honor societies. She began working with the CPRP in 2016 at the end of her first year of residency. Her clinical and research interests fall in the areas of consultation-liaison psychiatry and neuropsychiatry, with a special interest in somatic symptom and functional neurological disorders.
Hermioni Lokko, MD, MPP, is an Instructor in Psychiatry at Harvard Medical School (HMS) as well as, staff physician on the Medical Psychiatry Service at Brigham and Women's Hospital (BWH) and the Department of Psychosocial Oncology and Palliative Care at the Dana-Farber Cancer Institute (DFCI). She is also the Associate Training Director of the BWH/HMS psychiatry residency training Program. Her areas of interest include the impact of psychiatric illness, management strategies and palliative care in diverse cancer patients to develop innovative and practical psychological interventions for cancer patients and their care givers. She is currently the principal investigator for a Harvard Medical School funded project seeking to develop a positive psychology intervention to improve function and quality of life in hematopoietic stem cell transplant patients. She is an active co-investigator for the PEACE trial and assists with other projects at the CPRP. She is a graduate of the psychosomatic medicine/psycho-oncology fellowship at the BWH and DFCI, the adult psychiatry residency training program at the Massachusetts General Hospital and McLean Hospital, Harvard Medical School and Harvard Kennedy School of Government.
Social Work and Nursing Interventionists:
Special thanks: Our work has also been generously supported by the esteemed Avery D. Weisman, MD, of the eponymous Massachusetts General Hospital Psychiatry Consultation Service and a long-standing national leader in psychosomatic medicine. His support has allowed the CPRP to continue to investigate the associations between positive and negative emotional states and physical health and well-being, and we are forever indebted.
Total Health Pragmatic collaborative care for cardiac inpatients with depression or anxiety National Institutes of Health: National Heart Lung and Blood Institute (1R01HL133149-01A1)
This is a randomized controlled trial aiming to determine whether a blended, collaborative care intervention for heart disease and mood or anxiety disorders (the Total Health program) leads to improvements in quality of life and other patient outcomes during and after treatment.
Principal Investigator (PI): Jeff Huffman
Positive Emotions after Acute Coronary Events (PEACE) Developing a positive psychology intervention to improve cardiac health behaviors National Institutes of Health: National Heart Lung and Blood Institute (1R01HL113272-01A1)
This project aims to systematically develop a positive psychological intervention for patients with a recent acute coronary syndrome to determine if such an intervention leads to greater participation in health behaviors (e.g., better diet, more physical activity) in the weeks and months following the acute cardiac event.
A Positive Psychology-Motivational Interviewing Intervention for Type II Diabetes (BEHOLD-8) A psychological-behavioral intervention for physical activity in type 2 diabetes National Institute of Diabetes and Digestive and Kidney Diseases, R21DK109313
This is a randomized pilot trial of an intervention (planned N=60) combining positive psychological and goal-setting programs to improve physical activity in people with type 2 diabetes. Outcome measures include assessments of feasibility, acceptability and physical activity.
Principal Investigator (PI): Christopher Celano
Researching Emotions and Cardiac Health (REACH) A positive psychology intervention to promote health behaviors in patients with heart failure: A randomized, controlled pilot trial National Institutes of Health(K23 2017P001584)
This project aims to evaluate an optimized positive psychological intervention for patients with heart failure to explore potential benefits of the intervention on outcomes of interest (e.g., psychological health, functioning, and health behavior adherence) compared to a motivational interviewing- (MI) based education condition and treatment as usual (TAU).
A Novel Psychological-Behavioral Intervention to Increase Activity in Type 2 Diabetes (BEHOLD-16) American Diabetes Association
This is a 16-week study of a phone-based combined Positive Psychology-Motivational Interviewing intervention aimed to improve physical activity in patients who have type 2 diabetes and are suboptimally physically active. It will involve two parts: 1) a single-arm trial to assess feasibility and 2) a larger 16-week randomized trial in which the PP-MI program is tested against an attentional control condition.
Dexmedetomidine in Patients with Probable Alzheimer’s Disease
A phase 1b, randomized, placebo-controlled, single ascending or descending, single site study of dexmedetomidine in healthy elderly participants and patients with mild probable Alzheimer’s Disease
This randomized controlled trial aims to determine the safety and efficacy of dexmedetomidine as an intravenous sedative for patients with mild probable Alzheimer’s Disease (N=8). Outcome measures include optimal dosing for light sedation, cardiovascular parameters, and pharmacokinetic blood sample analysis.
Positive Affect in the Transplantation of Hematopoietic Stem Cells (PATH)
Development of a positive psychology intervention to improve mood and health related quality of life in patients post hematopoietic stem cell transplantation
Harvard Medical School, Dupont-Warren Fellowship
The goal of this study is to determine the feasibility of a phone-based positive psychology intervention for cancer patients who have recently undergone a hematopoietic stem cell transplant. The intervention aims to improve positive affect, psychological well-being, quality of life, and overall function and outcomes for these patients.
Principal Investigator (PI): Hermioni Lokko
Testing the Feasibility and Preliminary Efficacy of a Multilevel Intervention to Promote Physical Activity Among Patients with Metabolic Syndrome National Institutes of Health
The goal of this pilot project is to identify insufficiently active primary care patients with metabolic syndrome and help them increase their physical activity through a group multilevel behavioral intervention. This project will develop and test a combined positive psychology and motivational interviewing intervention in a group-setting and test the feasibility and acceptability of the intervention in people with metabolic syndrome.
Principal Investigator (PI): Rachel Millstein
A Program to Improve Outcomes in Patients with Non-Cardiac Chest Pain (NCCP) Anonymous donor funding
This is a project to pilot test a multidisciplinary care management program to optimize diagnosis and management of persons with persistent chest pain despite a negative cardiac assessment.
Principal Investigators (PIs): Jeff Huffman, Elizabeth Madva
Real-time Assessment of Suicide Risk Among Psychiatric Inpatients Donor funding
This project utilizes a combination of wrist-worn physiological monitors (assessing physical activity, heart rate, and electrodermal activity), frequently given brief questionnaires concerning mood and thoughts of self-injury administered on a smart phone, and software to track cellphone usage, in order to evaluate the factors which might predict thoughts of suicide during inpatient psychiatric treatment.
Principal Investigator (PI): Matthew Nock
Recently Completed Projects
Gratitude Research in Acute Coronary Events (GRACE) The impact of gratitude on biology and behavior in persons with heart disease Greater Good Science Center/Templeton Foundation
This project prospectively studied the connections between positive psychological states (e.g., gratitude, optimism), measured two weeks after an acute coronary syndrome, and improvements in biomarkers and health behaviors at 6 months.
Campbell KA, Healy BC, Celano CM, Albanese AM, Millstein RA, Huffman JC. Predictors of completion of a psychological-behavioral intervention in acute coronary syndrome patients. J Psychosom Res. 2018 Sep. doi: 10.1016/j.jpsychores.2018.06.006
Celano CM, Villegas AC, Albanese AM. Gaggin HK, Huffman JC. Depression and Anxiety in Heart Failure: A Review. Harv Rev Psychiatry. 2018 Jul/Aug. doi: 10.1097/HRP.0000000000000162.
Leclaire K, Cecil A, LaRussa A, Stuart F, Hemond CC, Healy BC, Chitnis T, Weiner H, Huffman JC, Glanz BI. Short Report: A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis. Int J MS Care. 2018 May-Jun; 20(3):136-141. doi: 10.7224/1537-2073.2017-002.
Bhasin MK, Denninger JW, Huffman JC, Joseph MG, Niles H, Chad-Friedman E, Goldman R, Buczynski-Kelley B, Mahoney BA, Fricchione GL, Dusek JA, Benson H, Zusman RM, Liebermann TA. Specific Transcriptome Changes Associated with Blood Pressure Reduction in Hypertensive Patients After Relaxation Response Training. J Altern Complement Med. 2018 May;24(5):486-504. doi: 10.1089/acm.2017.0053. Epub 2018 Apr 4.
Kleiman EM, Turner BJ, Fedor S, Beale EE, Picard RW, Huffman JC, Nock MK. Digital phenotyping of suicidal thoughts. Depress Anxiety. 2018 Apr 10. doi: 10.1002/da.22730.
Celano CM, Albanese AM, Millstein RA, Mastromauro CA, Chung WJ, Campbell KA, Legler SR, Park ER, Healy BC, Collins LM, Januzzi JL, Huffman JC. Optimizing a positive psychology intervention to promote health behaviors following an acute coronary syndrome: The Positive Emotions after Acute Coronary Events-III (PEACE-III) randomized factorial trial. Psychosom Med. 2018 Apr 5. doi: 10.1097/PSY.0000000000000584.
Millstein RA, Quintiliani LM, Sharpe AL. Society of Behavioral Medicine (SBM) position statement: Increasing funding for the NIH OBSSR to promote timely and effective behavioral medicine research. Transl Behav Med. 2018 Mar 1;8(2):309-312. doi: 10.1093/tbm/ibx022.
Mohammadi N, Aghayousefi A, Nikrahan GR, Adams CN, Alipour A, Sadeghi M, Roohafza H, Celano CM, Huffman JC. A randomized trial of an optimism training intervention in patients with heart disease. Gen Hosp Psychiatry. 2018 Mar - Apr;51:46-53. doi: 10.1016/j.genhosppsych.2017.12.004.
Massey CN, Feig EH, Duque-Serrano L, Huffman JC. Psychological Well-Being and Type 2 Diabetes. Curr Res Diabetes Obes J. 2017 Oct;4(4). pii: 555641.
Beach SR, Celano CM, Sugrue AM, Adams C, Ackerman MJ, Noseworthy PA, Huffman JC. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics. 2018 Mar - Apr;59(2):105-122. doi: 10.1016/j.psym.2017.10.009.
Cain KL, Gavand KA, Conway TL, Geremia CM, Millstein RA, Frank LD, Saelens BE, Adams MA, Glanz K, King AC, Sallis JF. Developing and Validating an Abbreviated Version of the Microscale Audit for Pedestrian Streetscapes (MAPS-Abbreviated). J Transp Health. 2017 Jun;5:84-96. doi: 10.1016/j.jth.2017.05.004. Epub 2017 May 26.
Huffman JC, Adams CN, Celano CM. Collaborative Care and Related Interventions in Patients With Heart Disease: An Update and New Directions. Psychosomatics. 2018 Jan - Feb;59(1):1-18. doi: 10.1016/j.psym.2017.09.003. Epub 2017 Sep 18.
Madva EN, Gomez-Bernal F, Millstein RA, Celano CM, Park ER, Mastromauro CA, Albanese AM, Beale EE, Huffman JC. Magnitude and sources of distress in mid-life adults with chronic medical illness: an exploratory mixed-methods analysis. Psychol Health Med. 2018 Jun;23(5):555-566. doi: 10.1080/13548506.2017.1384554.
Villegas AC, DuBois CM, Celano CM, Beale EE, Mastromauro CA, Stewart JG, Auerbach RP, Huffman JC, Hoeppner BB. A longitudinal investigation of the Concise Health Risk Tracking Self-Report (CHRT-SR) in suicidal patients during and after hospitalization. Psychiatry Res. 2017 Sep 20. pii: S0165-1781(16)31863-7. doi: 10.1016/j.psychres.2017.09.044.
McCoy TH, Castro VM, Snapper L, Hart K, Januzzi JL, Huffman JC, Perlis RH. Polygenic loading for major depression is associated with specific medical comorbidity. Transl Psychiatry. 2017 Sep 19;7(9):e1238. doi: 10.1038/tp.2017.201.
Beach SR, Gomez-Bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: A systematic review. Gen. Hosp. Psychiatry. 2017;48:1-19.
Huffman JC, Legler SR, Boehm JK. Positive psychological well-being and health in patients with heart disease: a brief review. Future Cardiol. 2017 Aug 22. doi: 10.2217/fca-2017-0016.
Kaar JL, Luberto CM, Campbell KA, Huffman JC. Sleep, health behaviors, and behavioral interventions: Reducing the risk of cardiovascular disease in adults. World J Cardiol. 2017 May 26;9(5):396-406.
Kleiman EM, Turner BJ, Fedor S, Beale EE, Huffman JC, Nock MK. Examination of real-time fluctuations in suicidal ideation and its risk factors: Results from two ecological momentary assessment studies. J Abnorm Psychol. 2017 Aug;126(6):726-738.
Campbell KA, Madva EN, Villegas AC, Beale EE, Beach SR, Wasfy JH, Albanese AM, Huffman JC. Non-cardiac Chest Pain: A Review for the Consultation-Liaison Psychiatrist. Psychosomatics. 2017 May - Jun;58(3):252-265.
Huffman JC, Millstein RA, Mastromauro CA, Moore SV, Celano CM, Bedoya CA, Suarez L, Boehm JK, Januzzi JL. A Positive Psychology Intervention for Patients with an Acute Coronary Syndrome: Treatment Development and Proof-of-Concept Trial. J Happiness Stud. 2016 Oct;17(5):1985-2006.
Celano CM, Beale EE, Mastromauro CA, Stewart JG, Millstein RA, Auerbach RP, Bedoya CA, Huffman JC. Psychological interventions to reduce suicidality in high-risk patients with major depression: a randomized controlled trial. Psychol Med 2016;47(5):810-821.
Campbell KA, Madva E, Villegas AC, Beale EE, Beach SR, Wasfy J, Albanese AM, Huffman JC. Non-cardiac Chest Pain: A Review for the Consultation-Liaison Psychiatrist. Psychosomatics 2016;58(3):252-265.
Celano CM, Beale EE, Beach SR, Belcher AM, Suarez L, Motiwala SR, Gandhi PU, Gaggin H, Januzzi JL Jr, Healy BC, Huffman JC. Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome. Psychosom Med. 2016;79(3):318-326.
Kubzansky LD, Kim ES, Salinas J, Huffman JC, Kawachi I. Happiness, health, and mortality. Lancet. 2016;388(10039):27.
Panagioti M, Bower P, Kontopantelis E, Lovell K, Gilbody S, Waheed W, Dickens C, Archer J, Simon G, Ell K, Huffman JC, Richards DA, van der Feltz-Cornelis C, Adler DA, Bruce M, Buszewicz M, Cole MG, Davidson KW, de Jonge P, Gensichen J, Huijbregts K, Menchetti M, Patel V, Rollman B, Shaffer J, Zijlstra-Vlasveld MC, Coventry PA. Association Between Chronic Physical Conditions and the Effectiveness of Collaborative Care for Depression: An Individual Participant Data Meta-analysis. JAMA Psychiatry. 2016;73(9):978-989.
Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016, Nov; 18(11):101.
Huffman JC, Albanese AM, Campbell KA, Celano CM, Millstein RA, Mastromauro CA, Healy BC, Chung WJ, Januzzi JL, Collins LM, Park ER. The Positive Emotions after Acute Coronary Events (PEACE) Behavioral Health Intervention: Design, Rationale, and Preliminary Feasibility of a Factorial Design Study. Clinical Trials. 2017 Apr;14(2):128-139.
Millstein, RA, Celano, CM, Beale, EE, Beach, SR, Suarez, L, Belcher AM, Januzzi, JL, Huffman, JC. The effects of optimism and gratitude on adherence, functioning, and mental health following an acute coronary syndrome. Gen Hosp Psychiatry. 2016, 43:17-22.
Rundell JR, Huffman JC. The COMPASS initiative: implementing a complex integrated care program. Gen Hosp Psychiatry. 2016, Jul 12. pii: S0163-8343(16)30168-2.
DuBois CM, Millstein RA, Celano CM, Wexler DJ, Huffman JC. Feasibility and Acceptability of a Positive Psychological intervention for patients with type 2 diabetes. Prim Care Companion CNS Disord. 2016, May 5;18(3).
Nikrahan GR, Suarez L, Asgari K, Beach SR, Celano CM, Kalantari M, Abedi MR, Etesampour A, Abbas R, Huffman JC. Positive Psychology Interventions for Patients With Heart Disease: A Preliminary Randomized Trial. Psychosomatics. 2016;57(4):348-358.
Nikrahan GR, Laferton JA, Asgari K, Kalantari M, Abedi MR, Etesampour A, Rezaei A, Suarez L, Huffman JC. Effects of Positive Psychology Interventions on Risk Biomarkers in Coronary Patients: A Randomized, Wait-List Controlled Pilot Trial. Psychosomatics. 2016;57(4):359-368.
Soule MC, Beale EE, Suarez L, Beach SR, Mastromauro CA, Celano CM, Moore SV, Huffman JC. Understanding motivations to participate in an observational research study: Why do patients enroll? Soc Work Health Care. 2016;55(3):231-246.
Celano CM, Healy B, Suarez L, Levy DE, Mastromauro C, Januzzi JL, Huffman JC. Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness. Value Health. 2016;19(2):185-191.
Huffman JC, Beale EE, Celano CM, Beach SR, Belcher AM, Moore SV, Suarez L, Motiwala SR, Gandhi PU, Gaggin HK. Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome The Gratitude Research in Acute Coronary Events Study. Circ Cardiovasc Qual Outcomes. 2016;9(1):55-63.
Huffman JC, Boehm JK, Beach SR, Beale EE, DuBois CM, Healy BC. Relationship of optimism and suicidal ideation in three groups of patients at varying levels of suicide risk. J Psychiatr Res. 2016;77:76-84.
Freudenreich O, Huffman JC, Sharpe M, Beach SR, Celano CM, Chwastiak LA, Cohen MA, Dickerman A, Fitz-Gerald MJ, Kontos N, Mittal L, Nejad SH, Niazi S, Novak M, Philbrick K, Rasimas JJ, Shim J, Simpson SA, Walker A, Walker J, Wichman CL, Zimbrean P, Sollner W, Stern TA. Updates in Psychosomatic Medicine: 2014. Psychosomatics. 2015;56(5):445-459.
Huffman JC, Celano CM. Depression in cardiovascular disease: From awareness to action. Trends Cardiovasc Med. 2015;25(7):623-624.
Beach SR, Walker J, Celano CM, Mastromauro CA, Sharpe M, Huffman JC. Implementing collaborative care programs for psychiatric disorders in medical settings: a practical guide. Gen Hosp Psychiatry. 2015;37(6):522-527.
DuBois CM, Lopez OV, Beale EE, Healy BC, Boehm JK, Huffman JC. Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: a systematic review. Int J Cardiol. 2015;195:265-280.
Suarez L, Beach SR, Moore SV, Mastromauro CA, Januzzi JL, Celano CM, Chang TE, Huffman JC. Use of the Patient Health Questionnaire-9 and a detailed suicide evaluation in determining imminent suicidality in distressed patients with cardiac disease. Psychosomatics. 2015;56(2):181-189.
Huffman JC, Beale EE, Beach SR, Celano CM, Belcher AM, Moore SV, Suarez L, Gandhi PU, Motiwala SR, Gaggin H, Januzzi JL. Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study. Contemp Clin Trials. 2015;44:11-19.
Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J. 2015;170(6):1105-1115.
Huffman J, Millstein R, Mastromauro C, Moore S, Celano C, Bedoya C, Suarez L, Boehm J, Januzzi J. A Positive Psychology Intervention for Patients with an Acute Coronary Syndrome: Treatment Development and Proof-of-Concept Trial. J Happiness Stud. 2015:1-22.
Huffman JC, DuBois CM, Millstein RA, Celano CM, Wexler D. Positive psychological interventions for patients with type 2 diabetes: rationale, theoretical model, and intervention development. J Diabetes Res. 2015;2015:428349.
Huffman JC, Moore SV, DuBois CM, Mastromauro CA, Suarez L, Park ER. An exploratory mixed methods analysis of adherence predictors following acute coronary syndrome. Psychol Health Med. 2015;20(5):541-550.
Huffman JC, DuBois CM, Mastromauro CA, Moore SV, Suarez L, Park ER. Positive psychological states and health behaviors in acute coronary syndrome patients: A qualitative study. J Health Psychol. 2014 64:27-34.
Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry. 2014;75(5):e441-449.
Huffman JC, Niazi SK, Rundell JR, Sharpe M, Katon WJ. Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the Academy of Psychosomatic Medicine Research and Evidence-Based Practice Committee. Psychosomatics. 2014;55(2):109-122.
Huffman JC, Mastromauro CA, Beach SR, Celano CM, DuBois CM, Healy BC, Suarez L, Rollman BL, Januzzi JL. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med. 2014;174(6):927-935.
Huffman JC, DuBois CM, Healy BC, Boehm JK, Kashdan TB, Celano CM, Denninger JW, Lyubomirsky S. Feasibility and utility of positive psychology exercises for suicidal inpatients. Gen Hosp Psychiatry. 2014;36(1):88-94.
Denninger JW, Bhasin M, Huffman J, Niles H, Creager M, Pande R, Liberman T, Fricchione G, Benson H, Zusman R. Clinical and genomic effects of a relaxation response-based mind-body intervention in stage I hypertension. The Journal of Alternative and Complementary Medicine. 2014;20(5):A54-A54.
Rollman BL, Huffman JC. Treating anxiety in the presence of medical comorbidity: calmly moving forward. Psychosom Med. 2013;75(8):710-712.
Beach SR, Januzzi JL, Mastromauro CA, Healy BC, Beale EE, Celano CM, Huffman JC. Patient Health Questionnaire-9 score and adverse cardiac outcomes in patients hospitalized for acute cardiac disease. J Psychosom Res. 2013;75(5):409-413.
Huffman JC. Review: depression after myocardial infarction is associated with increased risk of all-cause mortality and cardiovascular events. J Psychosom Res. 2013;16(4):110.
Huffman JC, Beach SR, Suarez L, Mastromauro CA, Dubois CM, Celano CM, Rollman BL, Januzzi JL. Design and baseline data from the Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized controlled trial. Contemp Clin Trials. 2013;36(2):488-501.
Celano CM, Suarez L, Mastromauro C, Januzzi JL, Huffman JC. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease. Circ Cardiovasc Qual Outcomes. 2013;6(4):498-504.
Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54(1):1-13.
Sowden GL, Mastromauro CA, Seabrook RC, Celano CM, Rollman BL, Huffman JC. Baseline physical health-related quality of life and subsequent depression outcomes in cardiac patients. Psychiatry Res. 2013;208(3):288-290.
Celano CM, Beale EE, Moore SV, Wexler DJ, Huffman JC. Positive psychological characteristics in diabetes: a review. Curr Diab Rep. 2013;13:917-929.
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013;2013:695925.
Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012;109(9):1266-1271.
DuBois CM, Beach SR, Kashdan TB, Nyer MB, Park ER, Celano CM, Huffman JC. Positive psychological attributes and cardiac outcomes: associations, mechanisms, and interventions. Psychosomatics. 2012;53(4):303-318.
Caro MA, Sowden GL, Mastromauro CA, Mahnks S, Beach SR, Januzzi JL, Huffman JC. Risk factors for positive depression screens in hospitalized cardiac patients. J Cardiol. 2012;60(1):72-77.
Wexler DJ, Porneala B, Chang Y, Huang ES, Huffman JC, Grant RW. Diabetes differentially affects depression and self-rated health by age in the U.S. Diabetes Care. 2012;35(7):1575-1577.
Celano CM, Mastromauro CA, Lenihan EC, Januzzi JL, Rollman BL, Huffman JC. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. Psychosom Med. 2012;74(1):93-99.
Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19(3):130-142.
Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes. 2011;4(2):198-205.
Huffman JC, Mastromauro CA, Sowden GL, Wittmann C, Rodman R, Januzzi JL. A collaborative care depression management program for cardiac inpatients: depression characteristics and in-hospital outcomes. Psychosomatics. 2011;52(1):26-33.
Huffman JC, Mastromauro CA, Boehm JK, Seabrook R, Fricchione GL, Denninger JW, Lyubomirsky S. Development of a positive psychology intervention for patients with acute cardiovascular disease. Heart Int. 2011;6(2):e14.
Bauer LK, Huffman JC. Is low cholesterol associated with depression in cardiac patients? Int J Cardiol. 2010;145(3):537-539.
Sowden G, Mastromauro CA, Januzzi JL, Fricchione GL, Huffman JC. Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J. 2010;159(5):780-787.
Huffman JC, Celano CM, Januzzi JL. The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes. Neuropsychiatr Dis Treat. 2010;6:123-136.
Huffman JC, Doughty CT, Januzzi JL, Pirl WF, Smith FA, Fricchione GL. Screening for major depression in post-myocardial infarction patients: operating characteristics of the Beck Depression Inventory-II. Int J Psychiatry Med. 2010;40(2):187-197.
Huffman JC, Smith FA, Fricchione GL, Januzzi JL, Nadelman S, Pirl WF. Depression and failure of cholesterol lowering after acute myocardial infarction. Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.08m00766.
Huffman JC. Could being happy give you a healthy heart? Future Cardiol. 2009;5(4):325-327.
Sowden GL, Huffman JC. The impact of mental illness on cardiac outcomes: a review for the cardiologist. Int J Cardiol. 2009;132(1):30-37.
Huffman JC, Smith FA, Blais MA, Taylor AM, Januzzi JL, Fricchione GL. Pre-existing major depression predicts in-hospital cardiac complications after acute myocardial infarction. Psychosomatics. 2008;49(4):309-316.
Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL. Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. J Psychosom Res. 2008;65(6):557-563.
Back to Top